La Jolla Pharmaceutical Company , a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that detailed results from its Phase 2 study of GCS-100 in chronic kidney disease patients are being
glomerular הגייה עם משמעויות, מילים נרדפות, הפכים, תרגומים, משפטים ועוד